Hi Team, We are trying to utilize the maximum potential of cTAKES to meet the requirements for our profile, where we have a requirement to extract the sentences from the medical document. We have seen cTAKES already providing the list of sentences in the clinical text within the object as below
[cid:image002.png@01D64027.944FD390] We also notice that sentences are delimited based on the below predefined delimiters, which was actually a problem in our requirement where sentences were seggregated whenever one of the below tokens are encountered. [cid:image005.jpg@01D64029.1E6AC980] For eg: "Patient was taking Paracetamol (650 mg) thrice daily" , was splitted to two different sentences(because a ')' encountered) 1. Patient was taking Paracetamol (650 mg) 2. thrice daily So we tried to customize it by removing some of the defined delimiters to meet our requirement. Actually we tried with just '.' As delimiter and found sentences are splitted whenever a '.' Is encountered Since this is a change done at the core module , we would like to know whether this is going to impact the clinical token identification process or going to have impact on the already provided informations like tlink,timex or any other critical attribute. Kindly advice. Thanks & Regards [cid:D3145E69-CD94-48C1-877F-5134EEAFB598] Abad Ayyub Vnet: 406170 | Cell : +91-9447379028 This e-mail and any files transmitted with it are for the sole use of the intended recipient(s) and may contain confidential and privileged information. If you are not the intended recipient(s), please reply to the sender and destroy all copies of the original message. Any unauthorized review, use, disclosure, dissemination, forwarding, printing or copying of this email, and/or any action taken in reliance on the contents of this e-mail is strictly prohibited and may be unlawful. Where permitted by applicable law, this e-mail and other e-mail communications sent to and from Cognizant e-mail addresses may be monitored. This e-mail and any files transmitted with it are for the sole use of the intended recipient(s) and may contain confidential and privileged information. If you are not the intended recipient(s), please reply to the sender and destroy all copies of the original message. Any unauthorized review, use, disclosure, dissemination, forwarding, printing or copying of this email, and/or any action taken in reliance on the contents of this e-mail is strictly prohibited and may be unlawful. Where permitted by applicable law, this e-mail and other e-mail communications sent to and from Cognizant e-mail addresses may be monitored.
